dc.contributor.author | Gurriarán Rodríguez, Uxía | |
dc.contributor.author | Al-Massadi Iglesias, Omar | |
dc.contributor.author | Roca Rivada, Arturo | |
dc.contributor.author | Crujeiras Martínez, Ana Belén | |
dc.contributor.author | Gallego, Rosalía | |
dc.contributor.author | Pardo Pérez, María | |
dc.contributor.author | Seoane Camino, Luisa Maria | |
dc.contributor.author | Pazos Randulfe, Yolanda | |
dc.contributor.author | Casanueva Freijo, Felipe | |
dc.contributor.author | Pérez Camiña, Jesús | |
dc.date.accessioned | 2017-06-07T07:22:00Z | |
dc.date.available | 2017-06-07T07:22:00Z | |
dc.date.issued | 2011 | |
dc.identifier.issn | 1582-1838 | |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/5592 | |
dc.description.abstract | The role of obestatin, a 23-amino-acid peptide encoded by the ghrelin gene, on the control of the metabolism of pre-adipocyte and adipocytes as well as on adipogenesis was determined. For in vitro assays, pre-adipocyte and adipocyte 3T3-L1 cells were used to assess the obestatin effect on cell metabolism and adipogenesis based on the regulation of the key enzymatic nodes, Akt and AMPK and their downstream targets. For in vivo assays, white adipose tissue (WAT) was obtained from male rats under continuous subcutaneous infusion of obestatin. Obestatin activated Akt and its downstream targets, GSK3alpha/beta, mTOR and S6K1, in 3T3-L1 adipocyte cells. Simultaneously, obestatin inactivated AMPK in this cell model. In keeping with this, ACC phosphorylation was also decreased. This fact was confirmed in vivo in white adipose tissue (omental, subcutaneous and gonadal) obtained from male rats under continuous sc infusion of obestatin (24 and 72 hrs). The relevance of obestatin as regulator of adipocyte metabolism was supported by AS160 phosphorylation, GLUT4 translocation and augment of glucose uptake in 3T3-L1 adipocyte cells. In contrast, obestatin failed to modify translocation of fatty acid transporters, FATP1, FATP4 and FAT/CD36, to plasma membrane. Obestatin treatment in combination with IBMX and DEX showed to regulate the expression of C/EBPalpha, C/EBPbeta, C/EBPdelta and PPARgamma promoting adipogenesis. Remarkable, preproghrelin expression, and thus obestatin expression, increased during adipogenesis being sustained throughout terminal differentiation. Neutralization of endogenous obestatin secreted by 3T3-L1 cells by anti-obestatin antibody decreased adipocyte differentiation. Furthermore, knockdown experiments by preproghrelin siRNA supported that obestatin contributes to adipogenesis. In summary, obestatin promotes adipogenesis in an autocrine/paracrine manner, being a regulator of adipocyte metabolism. These data point to a putative role in the pathogenesis of metabolic syndrome. | |
dc.language.iso | eng | |
dc.title | Obestatin as a regulator of adipocyte metabolism and adipogenesis | |
dc.type | Artigo | es |
dc.authorsophos | Gurriaran-Rodriguez, Uxia | |
dc.authorsophos | Al-Massadi, Omar | |
dc.authorsophos | Roca-Rivada, Arturo | |
dc.authorsophos | Belen Crujeiras, Ana | |
dc.authorsophos | Gallego, Rosalia | |
dc.authorsophos | Pardo, Maria | |
dc.authorsophos | Maria Seoane, Luisa | |
dc.authorsophos | Pazos, Yolanda | |
dc.authorsophos | Casanueva, Felipe F. | |
dc.authorsophos | Camina, Jesus P. | |
dc.identifier.doi | 10.1111/j.1582-4934.2010.01192.x | |
dc.identifier.isi | 294597400012 | |
dc.identifier.pmid | 21029370 | |
dc.identifier.sophos | 10071 | |
dc.issue.number | 9 | |
dc.journal.title | JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Endocrinoloxía | |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago | |
dc.page.initial | 1927 | |
dc.page.final | 1940 | |
dc.rights.accessRights | openAccess | |
dc.typesophos | Artículo Original | |
dc.volume.number | 15 | |